Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Premeir Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Premeir Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Fieve Clinical Research
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Fieve Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Medical & Behavioral Health Research
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Medical & Behavioral Health Research
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
NYU School of Medicine
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
The Medical Research Network, LLC
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Village Clinical Research Inc.
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Village Clinical Research Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
IPS Research Company
mi
from
Oklahoma City, OK
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Summit Research Network
mi
from
Portland, OR
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Summit Research Network
mi
from
Portland, OR
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Suburban Research Associates
mi
from
Media, PA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Keystone Clinical Studies, Llc
mi
from
Norristown, PA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Keystone Clinical Studies, Llc
mi
from
Norristown, PA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Sleep Diagnosists and Treatment Centers
mi
from
West Chester, PA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Sleep Diagnosists and Treatment Centers
mi
from
West Chester, PA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Houston Clinical Trials, LLC
mi
from
Houston, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Neuropsychiatric Associates
mi
from
Woodstock, VT
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Neuropsychiatric Associates
mi
from
Woodstock, VT
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
NeuroScience, Inc.
mi
from
Herndon, VA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Dean Foundation
mi
from
Middleton, WI
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Dean Foundation
mi
from
Middleton, WI
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Eastside Therapeutic Resource
mi
from
Middleton, WI
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Eastside Therapeutic Resource
mi
from
Middleton, WI
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Woodhull Medical & Mental Health Center
mi
from
Staten Island, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Woodhull Medical & Mental Health Center
mi
from
Staten Island, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Midwest Research Group
mi
from
Saint Charles, MO
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels of Repetitive Behavior
Status: Enrolling
Updated:  5/2/2017
UCLA
mi
from
Los Angeles, CA
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels of Repetitive Behavior
Status: Enrolling
Updated: 5/2/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Status: Enrolling
Updated:  5/2/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Status: Enrolling
Updated: 5/2/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
LifeCourse: A Supportive Care Approach for Patients Late in Life
LifeCourse: A Supportive Care Approach for Patients Late in Life
Status: Enrolling
Updated:  5/3/2017
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
LifeCourse: A Supportive Care Approach for Patients Late in Life
LifeCourse: A Supportive Care Approach for Patients Late in Life
Status: Enrolling
Updated: 5/3/2017
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
LifeCourse: A Supportive Care Approach for Patients Late in Life
LifeCourse: A Supportive Care Approach for Patients Late in Life
Status: Enrolling
Updated:  5/3/2017
Augustana Health Care Center
mi
from
Minneapolis, MN
LifeCourse: A Supportive Care Approach for Patients Late in Life
LifeCourse: A Supportive Care Approach for Patients Late in Life
Status: Enrolling
Updated: 5/3/2017
Augustana Health Care Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
LifeCourse: A Supportive Care Approach for Patients Late in Life
LifeCourse: A Supportive Care Approach for Patients Late in Life
Status: Enrolling
Updated:  5/3/2017
Walker Methodist Health Center
mi
from
Minneapolis, MN
LifeCourse: A Supportive Care Approach for Patients Late in Life
LifeCourse: A Supportive Care Approach for Patients Late in Life
Status: Enrolling
Updated: 5/3/2017
Walker Methodist Health Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated:  5/4/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated: 5/4/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated:  5/4/2017
Oregon Health and Science University
mi
from
Portland, OR
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated: 5/4/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
University of Rochester
mi
from
Rochester, NY
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
Hospital for Sick Children
mi
from
Toronto,
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Contact Allergens Causing Chronic Urticaria in a New England-Area Population
Status: Enrolling
Updated:  5/11/2017
Tufts Medical Center, Department of Dermatology
mi
from
Boston, MA
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Contact Allergens Causing Chronic Urticaria in a New England-Area Population
Status: Enrolling
Updated: 5/11/2017
Tufts Medical Center, Department of Dermatology
mi
from
Boston, MA
Click here to add this to my saved trials